Tilray Medical Receives Approval to Extend Market Authorization in Italy
22 sept. 2022 07h00 HE
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company...
Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany
06 sept. 2022 09h00 HE
|
Tilray Brands, Inc.
BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced...
Optimi Health Completes Expansion Of On-Site Analytical Laboratory
11 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed a...
Isracann Receives Project Characterization Report and Engages EU GMP Consultancy
09 janv. 2020 00h05 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a...
Isracann Enters MOU for European Distribution
02 janv. 2020 09h00 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based business focused on becoming a...
Isracann Enters MOU for European Distribution
02 janv. 2020 00h05 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based business focused on becoming a...